NeuroVive Completes Recruitment in 2nd Part of its Ongoing KL1333 Ph Ia/b Study
20 Dec 2019 //
PR NEWSWIRE
NeuroVive settles dispute with CicloMulsion regarding certain pharma technology
16 Dec 2019 //
PHARMABIZ
NeuroVive Receives Vinnova Funding to Support Development of NV354
15 Nov 2018 //
PR NEWSWIRE